Next54, formerly known as Health54, is the Corporate Venture Capital (CVC) vehicle of the CFAO Group.
Next54 now broadens its investment scope to encompass the 3 of CFAO Group’s division, i.e. Healthcare, Consumer and Green Infra and continues to work closely with Mobility54, the Group CVC for new mobility across Africa.
We see tremendous opportunities arising from the convergence of accelerated technology adoption, fast-growing economies and demographics, and the continuous structuring of various markets in Africa. We believe that innovation and digitization play a key role in addressing the continent's challenges and resolving fundamental issues.
Talent is abundant across the 54 countries, but entrepreneurship is often constrained by a lack of capital and resources needed to grow and scale transformative businesses in Africa. Through Next54, we support and accelerate the growth of innovative ventures with capital investment and active promotion of synergetic activities with the CFAO Group.
Company Details
- Employees
- 4
- Founded
- -
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
Next54 Questions
Next54's LinkedIn profile is https://www.linkedin.com/company/next54
Next54 has
4 employees.
View email and phone details for 4
employees at Next54.
Next54's industry is
Venture Capital and Private Equity Principals
Next54's top competitors are
Mobility54,
Surechill,
Novastar Ventures,
Sanofi,
Weadvise,
Chroma Impact Investment,
Gaia Impact,
Cfao,
Solina,
Reckitt.
Next54's categories are Venture Capital and Private Equity Principals
Next54's founding year is 2022
